George M. Milne, Jr.

Venture Partner at Radius Ventures LLC

George M. Milne, Jr.

George M. Milne, Jr.

Venture Partner at Radius Ventures LLC

Overview
Career Highlights

Phylogix, Inc.

RelSci Relationships

8085

Number of Boards

23

Birthday

1944

Age

75

Contact Data
Trying to get in touch with George M. Milne, Jr.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals George M. Milne, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Charles River Laboratories, Inc.

Relationship likelihood: Strong

Co-Founder at Radius Ventures LLC

Relationship likelihood: Strong

Vice Chairman & President at The New York Botanical Garden

Relationship likelihood: Strong

Dean at Tufts University - Cummings School of Veterinary Medicine

Relationship likelihood: Strong

President & Chief Executive Officer at Sea Research Foundation, Inc.

Relationship likelihood: Strong

Director at Allegro Diagnostics Corp.

Relationship likelihood: Strong

Partner at Lumira Capital Investment Management, Inc.

Relationship likelihood: Strong

Director Emeritus at Johns Hopkins University Applied Physics Laboratory LLC

Relationship likelihood: Strong

Senior Advisor at Essex Woodlands Management, Inc.

Relationship likelihood: Strong

Co-Founder at QLT, Inc.

Relationship likelihood: Strong

Paths to George M. Milne, Jr.
Potential Connections via
Relationship Science
You
George M. Milne, Jr.
Venture Partner at Radius Ventures LLC
Education
BS Chemistry

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

Ph.D Organic Chemistry

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Memberships
Member of the Corporation
Current

Draper is a not-for-profit research and development laboratory focused on the design, development, and deployment of advanced technological solutions for our nation’s most challenging and important problems in security, space exploration, healthcare, and energy. Our expertise includes the areas of guidance, navigation, and control systems; fault-tolerant computing; advanced algorithms and software solutions; modeling and simulation; and MEMS and multichip module technology. What We Do With a strong commitment to delivering working solutions to our sponsors, we apply our expertise to a variety of domains, including autonomous air, land, sea, and space systems; information integration; distributed sensors and networks; precision-guided munitions; and biomedical engineering; chemical/biological defense; and energy system modeling and management. When appropriate for the needs of our sponsors, we will work with commercial partners to transition our technology to commercial production.

Career History
Venture Partner
2002 - Current

Radius Ventures invests in leading-edge, growth equity and expansion-stage in healthcare and life sciences companies across all major sectors including biotechnology, medical devices, healthcare services and healthcare information technology. The firm looks for companies with exceptional management teams with strong track records, disruptive technologies and services, attractive market adoption dynamics, substantial barriers to competitive entry, highly profitable and sustainable business models, significant valuation inflection points expected in the near to mid-term and, strong prospects for the firm to leverage their network and experience to impact corporate development. Radius Ventures typically invest up to $10 million over initial and subsequent financing rounds, as a lead or syndicate investor.

Chairman
Tenure Unconfirmed

Phylogix, Inc. develops therapeutic drugs. It conducts research on tissue protection and oncology. The firm develops drug candidates in preclinical development, called FRIL to protect cancer patients from the toxic side-effects of chemotherapy. The company was founded in 1998 and is headquartered in Waltham, MA

President, Central Research
1970 - 2002

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Boards & Committees
Director
2005 - 2007

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Director
2003 - 2006

Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA.

Member of the Management Council
1970 - 2002

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$25K - $50K
2009

New York Botanical Garden scientists, postdoctoral researchers, Ph.D. candidates, research associates, highly-trained technical staff, interns, and volunteers work to explore, understand, document, conserve, and manage Earth’s plant, algal, and fungal diversity. Interrelated approaches promote multiple levels of discovery and rapid advancement of understanding. Systematics Geographic Area Programs. With a sustained network of active field research since 1891—and a particular focus on six geographic areas in the New and Old World—Garden scientists work with local colleagues and collaborating institutions to explore, understand, and conserve biological diversity. Plant Groups. With expertise across all of the major, ancient evolutionary lineages—algae, fungi, lichens, mosses, liverworts, ferns, gymnosperms—plus many groups of flowering plants that we see around us—Garden scientists carry fundamental knowledge for finding solutions to environmental and natural resource challenges now being brought about by rapid global change. Laboratory Research. With modern laboratories and state-of-the-art techniques such as DNA analysis, Garden scientists explore plants, algae, and fungi and their relationships at their most essential levels—pushing the boundaries of knowledge about life and leading to new discoveries. Conservation Conservation. With conservation initiatives to identify plant species at risk of extinction and inform plans to protect them and their ecosystems, Garden scientists reduce negative consequences for human well-being and the biological diversity of the planet at both local and global levels. Plants and People. With a focus on useful plants—both those that are global resources with great economic impact as well as species used regionally by indigenous peoples and local communities—Garden scientists find solutions for conserving and sustainably managing the plant resources on which the well-being of people depends. Outreach Training and Science Education. With a renowned professional staff and unmatched scientific facilities, the Garden trains the finest young botanists possible in order to expand knowledge about plant diversity and accelerate the translation and sharing of that knowledge for the benefit of humankind. Science Offerings & Events. With visitor-oriented exhibits, Gallery Talks, Science Open Houses, professional conferences, and more, the Garden enhances understanding and advances discovery about plants, algae, and fungi found around the world—and their relationships to each other, to their ecosystems, and to people

Political Donations
$500
2018

Senator from Connecticut

$500
2004

Former Representative from Connecticut's 2nd Congressional District

$250
2002

Former Representative from Connecticut's 2nd Congressional District

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by George M. Milne, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of George M. Milne, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and George M. Milne, Jr..